Results 131 to 140 of about 3,828,801 (363)

Modeling the Mass Distribution and Gravitational Potential of Nearby Disk Galaxies: Implications for the Interstellar Medium Dynamical Equilibrium

The Astrophysical Journal
We characterize stellar, gas, and dark matter mass distributions for 17 nearby massive disk galaxies from the PHANGS sample. This allows us to compute the gravitational potential that vertically confines the interstellar gas and determines its ...
Vivek Vijayakumar, Jiayi Sun, Eve C. Ostriker, Enrico M. Di Teodoro, Konstantin Haubner, Chang-Goo Kim, Adam K. Leroy, Miguel Querejeta   +7 more
doaj   +1 more source

What does (not) drive the variation of the low-mass end of the stellar initial mass function of early-type galaxies [PDF]

, 2020
C E Barbosa, C. Spiniello, M. Arnaboldi, L. Coccato, M. Hilker, T. Richtler, C E Barbosa, C. Spiniello, M. Arnaboldi, L. Coccato, M. Hilker, T. Richtler   +11 more
openalex   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

A supra-massive population of stellar-mass black holes in the globular cluster Palomar 5. [PDF]

Nat Astron, 2021
Gieles M, Erkal D, Antonini F, Balbinot E, Peñarrubia J.   +4 more
europepmc   +1 more source

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source

An Early Dark Matter–dominated Phase in the Assembly History of Milky Way–mass Galaxies Suggested by the TNG50 Simulation and JWST Observations

The Astrophysical Journal Letters
Whereas well-studied galaxies at cosmic noon are found to be baryon dominated within the effective radius, recent JWST observations of z ∼ 6–7 galaxies with stellar masses of only M _* ∼ 10 ^8−9 M _⊙ surprisingly indicate that they are dark matter ...
Anna de Graaff, Annalisa Pillepich, Hans-Walter Rix   +2 more
doaj   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

The Stellar Mass Function

, 1997
15 pages incl. 4 figures (LaTeX, style files included); The figures are larger than in the 12 page review that is to appear in PASPC: Brown Dwarfs and Extrasolar Planets, R. Rebolo, M.R. Zapatero Osorio and E.
openaire   +2 more sources

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source